Gene and metabolite expression dependence on body mass index in human myocardium

Sci Rep. 2022 Jan 26;12(1):1425. doi: 10.1038/s41598-022-05562-8.

Abstract

We hypothesized that body mass index (BMI) dependent changes in myocardial gene expression and energy-related metabolites underlie the biphasic association between BMI and mortality (the obesity paradox) in cardiac surgery. We performed transcriptome profiling and measured a panel of 144 metabolites in 53 and 55, respectively, myocardial biopsies from a cohort of sixty-six adult patients undergoing coronary artery bypass grafting (registration: NCT02908009). The initial analysis identified 239 transcripts with biphasic BMI dependence. 120 displayed u-shape and 119 n-shape expression patterns. The identified local minima or maxima peaked at BMI 28-29. Based on these results and to best fit the WHO classification, we grouped the patients into three groups: BMI < 25, 25 ≤ BMI ≤ 32, and BMI > 32. The analysis indicated that protein translation-related pathways were downregulated in 25 ≤ BMI ≤ 32 compared with BMI < 25 patients. Muscle contraction transcripts were upregulated in 25 ≤ BMI ≤ 32 patients, and cholesterol synthesis and innate immunity transcripts were upregulated in the BMI > 32 group. Transcripts involved in translation, muscle contraction and lipid metabolism also formed distinct correlation networks with biphasic dependence on BMI. Metabolite analysis identified acylcarnitines and ribose-5-phosphate increasing in the BMI > 32 group and α-ketoglutarate increasing in the BMI < 25 group. Molecular differences in the myocardium mirror the biphasic relationship between BMI and mortality.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Body Mass Index
  • Carnitine / analogs & derivatives
  • Carnitine / metabolism
  • Case-Control Studies
  • Cholesterol / biosynthesis
  • Cohort Studies
  • Coronary Artery Bypass / methods*
  • Coronary Artery Disease / genetics*
  • Coronary Artery Disease / metabolism
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / surgery
  • Female
  • Gene Expression Profiling
  • Humans
  • Immunity, Innate / genetics
  • Ketoglutaric Acids / metabolism
  • Lipid Metabolism / genetics
  • Male
  • Metabolome
  • Middle Aged
  • Muscle Contraction / genetics
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Obesity / genetics*
  • Obesity / metabolism
  • Obesity / mortality
  • Obesity / surgery
  • RNA, Messenger / classification
  • RNA, Messenger / genetics*
  • RNA, Messenger / metabolism
  • Risk Factors
  • Survival Analysis
  • Time Factors
  • Transcriptome*

Substances

  • Ketoglutaric Acids
  • RNA, Messenger
  • acylcarnitine
  • Cholesterol
  • Carnitine

Associated data

  • ClinicalTrials.gov/NCT02908009